Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous conditioned serum in alveolar ridge splitting surgery
IRCT20260817070692N1Phase 3Recruiting
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Nov 2026
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of autologous conditioned serum in Alveolar bone atrophy (ABL) and bone healing (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Quantity and quality of regenerated bone. Started Nov 2026; status: recruiting.
02
Drugs
autologous conditioned serum
03
Conditions
Alveolar bone atrophy (ABL)bone healing
Beyond the preview
Go deeper on IRCT20260817070692N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260817070692N1.